ObesityNCT03233906
The Effects of Chia on Overweight/Obese Women
A study testing Chia Seeds- Salvia Hispanica in people with Obesity and Eating Behavior, run by California State Polytechnic University, Pomona at 1 site in United States.
Trial summary
The purpose of the study is to examine the effect of chia seed consumption on body composition, blood pressure, blood glucose, satiety, mood, joint pain, and dietary displacement in overweight and obese females (18-45years). Read more about this study
- Who is it for?
- Ages 18 to 45 years, women onlyHealthy volunteers can take part
- Conditions the study is for
- Obesity, Eating Behavior, Mood
- What is being tested?
- Chia Seeds- Salvia Hispanica
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60 participants
- Where
- 1 siteUnited States
- Study dates
- 20 May 2017to Aug 2018
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 45 years
- Women only
- Healthy volunteers accepted
- Adult
Who may be able to join
- are a female.
- are between the ages of 18 and 45.
- are not averse to consuming chia seeds on a regular basis (at least six weeks).
- have not taken any medication for any chronic disease (heart, diabetes, cancer) for twelve weeks.
- have not taken any steroid or hormone medication in the last eight weeks, excluding birth control pills...
- do not consume excess amounts of nuts and seeds. - do not consume alcohol on a regular basis.
- are not currently on a diet plan.
- are not pregnant or plan to become pregnant.
Who cannot join
- are a child, teenager, woman, or male younger than 18 or older than 45.
- eat large quantities of chia seeds on a regular basis.
- are taking any steroid or hormone medication (other than birth control pills). - are taking laxatives or fiber containing supplements on a regular basis.
- are pregnant or become pregnant.
- are currently on a diet plan.
- have a known allergy to seeds.
Show all 9Show fewer
- consume excess amounts of seeds or nuts.
- consume alcohol on a regular basis.
- have a pacemaker or metal pins or plates in the body.
Trial locations and contacts
1 site in 1 country.
United States1 site
California State Polytechnic University, Pomona
Pomona, California, 91766
About this study
Official title: Effects of Chia Seed Consumption on Body Composition, Blood Pressure, Blood Glucose, Satiety, Diet Displacement, Joint Pain, Mood and Serotonin Levels in Young, Healthy, Overweight/Obese Females
The purpose of the study is to examine the effect of chia seed consumption on body composition, blood pressure, blood glucose, satiety, mood, joint pain, and dietary displacement in overweight and obese females (18-45years). It is hypothesized that consuming chia seeds will bring about a positive change in body composition (lower % body fat), satiety, mood, joint pain, and blood pressure, lower blood glucose levels, increased fiber and improved nutrient intake, in overweight/ obese females.
Read the detailed description
Specific Objectives: 1. Determine if chia seed diet addition of 10% of Kcals (CHIA) positively changes body composition in young, healthy, overweight/obese people (Tanita scale). A) Determine if CHIA will decrease blood pressure (monitor). 2. Determine if CHIA will decrease blood glucose (draw) 3. Determine if CHIA increases satiety and improves diet (recordings). 4. Determine if CHIA will decrease joint pain (questionnaire). 5. Determine if CHIA will increase positive mood changes (questionnaires) and increase blood serotonin levels (draw).
- Conditions
- Obesity, Eating Behavior, Mood, Glucose, Dietary Modification
- Being tested
- Chia Seeds- Salvia Hispanica
- Medical subject headings
- Obesity, Feeding Behavior
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Chia Seeds- Salvia HispanicaDietary supplement
Chia seed added-10% of kcals and a no-chia control diet. 10% will be calculated using the following formula: Harris-Benedict equation multiplied by the activity factor of 1.2, 1.375, and 1.55 depending on each participant's activity level based on the information provided on the initial screening form.
| Study group | Role | What they receive |
|---|---|---|
| Chia Seeds | Active comparator | 10% of a participants total kcal estimated needs given in chia seeds everyday for 8 weeks. Receives: Dietary Supplement: Chia Seeds- Salvia Hispanica |
| Control | No intervention | Habitual diet with avoidance of high fiber and high omega-3 fatty acid foods. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Fasting plasma glucose
12-hour fasting plasma glucose levels will be assessed using a glucometer
Measured: baseline
Waist Circumference
waist circumference will be measured for each participant
Measured: baseline
Caloric intake
9, 3-day diet journals will be collected using a paper method
Measured: baseline
Serotonin
Urine serotonin levels will be assessed
Measured: baseline
Body Weight
Tanita scale
Measured: Baseline
Body Mass Index
Tanita sclae
Measured: Baseline
Body Fat Percentage
Tanita scale
Measured: Baseline
Fasting plasma glucose
2-hour fasting plasma glucose levels will be assessed using a glucometer
Measured: week 4
Fasting plasma glucose
2-hour fasting plasma glucose levels will be assessed using a glucometer
Measured: week 8
Waist Circumference
waist circumference will be measured for each participant
Measured: week 4
Waist Circumference
waist will be measured for each participant
Measured: week 8
Caloric intake
9, 3-day diet journals will be collected using a paper method
Measured: week 4
Caloric intake
9, 3-day diet journals will be collected using a paper method
Measured: week 8
Serotonin
Urine serotonin levels will be assessed
Measured: week 4
Serotonin
Urine serotonin levels will be assessed
Measured: week 8
Body Weight
tanita scale
Measured: week 4
Body weight
tanita scale
Measured: week 8
Body mass index
tanita scale
Measured: week 4
body mass index
tanita scale
Measured: week 8
Body fat percentage
tanita scale
Measured: week 4
Body fat percentage
tanita scale
Measured: week 8
Hip Circumference
Hip Circumference will be measured for each participant
Measured: Baseline
Hip Circumference
Hip Circumference will be measured for each participant
Measured: week 4
Hip Circumference
Hip Circumference will be measured for each participant
Measured: week 8
Secondary outcomes (36)
Blood Pressure
Blood pressure will be taken using an automatic blood pressure machine
Measured: baseline
Blood Pressure
Blood pressure will be taken using an automatic blood pressure machine
Measured: week 4
Blood Pressure
Blood pressure will be taken using an automatic blood pressure machine
Measured: week 8
Joint Pain
Joint pain will be assessed using The WOMAC (Western Ontario and McMaster Universities) Index of Osteoarthritis
Measured: baseline
Joint Pain
Joint pain will be assessed using The WOMAC (Western Ontario and McMaster Universities) Index of Osteoarthritis
Measured: week 4
Joint Pain
Joint pain will be assessed using The WOMAC (Western Ontario and McMaster Universities) Index of Osteoarthritis
Measured: week 8
Mood
Major Depression Inventory
Measured: Baseline
Mood
Major Depression Inventory
Measured: week 4
Mood
Major Depression Inventory
Measured: week 8
Physical Activity
INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE (August 2002) SHORT LAST 7 DAYS SELF-ADMINISTERED FORMAT
Measured: Baseline
Physical Activity
INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE (August 2002) SHORT LAST 7 DAYS SELF-ADMINISTERED FORMAT
Measured: week 4
Physical Activity
INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE (August 2002) SHORT LAST 7 DAYS SELF-ADMINISTERED FORMAT
Measured: week 8
Sleep Quality
Measuring sleep quality using the Pittsburgh Sleep Quality Index
Measured: Baseline
Sleep Quality
Measuring sleep quality using the Pittsburgh Sleep Quality Index
Measured: week 4
Sleep Quality
Measuring sleep quality using the Pittsburgh Sleep Quality Index
Measured: week 8
Fat mass
using a tanita scale
Measured: Baseline
Fat mass
using a tanita scale
Measured: week 4
Fat mass
using a tanita scale
Measured: week 8
Fat Free Mass
using a tanita scale
Measured: Baseline
Fat Free Mass
using a tanita scale
Measured: week 4
Fat Free Mass
using a tanita scale
Measured: week 8
Total body water
using a tanita scale
Measured: Baseline
Total body water
using a tanita scale
Measured: week 4
Total body water
using a tanita scale
Measured: week 8
Macro nutrient intake
3, 3-day diet journals will be collected using a paper method
Measured: Baseline
Macro nutrient intake
3, 3-day diet journals will be collected using a paper method
Measured: week 4
Macro nutrient intake
3, 3-day diet journals will be collected using a paper method
Measured: week 8
Micronutrient intake
3, 3-day diet journals will be collected using a paper method
Measured: Baseline
Micronutrient intake
3, 3-day diet journals will be collected using a paper method
Measured: week 4
Micronutrient intake
3, 3-day diet journals will be collected using a paper method
Measured: week 8
Dietary intake Satiety
3, 3-day diet journals will be collected using a paper method
Measured: Baseline
Dietary intake Satiety
3, 3-day diet journals will be collected using a paper method
Measured: week 4
Dietary intake Satiety
3, 3-day diet journals will be collected using a paper method
Measured: week 8
Dietary intake displacement
3, 3-day diet journals will be collected using a paper method
Measured: Baseline
Dietary intake displacement
3, 3-day diet journals will be collected using a paper method
Measured: week 4
Dietary intake displacement
3, 3-day diet journals will be collected using a paper method
Measured: week 8
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted31 Jul 2017
- Study start20 May 2017
- Primary completionMay 2018 (estimated)
- Study completionAug 2018 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for ObesityStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Human subjects- females (18-45 y.o.) with a BMI greater than or equal to 26.
- Masking
- None (open label)
- Enrolment
- 60 participants (estimated)
Sponsor and investigators
- Lead sponsor
- California State Polytechnic University, Pomona
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Desiree Vera, California State Polytechnic University, Pomona
- Investigators
- Bonny Burns-Whitmore, DrPh, RD, Study director, California State Polytechnic University, Pomona
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03233906
- Sponsor's protocol ID
- IRB-16-188
- Status last verified
- May 2018
- First submitted
- 17 Jul 2017
- Last updated
- 11 May 2018
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 11 May 2018. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effects of Chia Seed Consumption on Body Composition, Blood Pressure, Blood Glucose, Satiety, Diet Displacement, Joint Pain, Mood and Serotonin Levels in Young, Healthy, Overweight/Obese Females
- ClinicalTrials.gov ID
- NCT03233906
- Acronym / sponsor ID
- IRB-16-188
- Conditions
- Obesity, Eating Behavior, Mood, Glucose, Dietary Modification
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 60 participants (estimated)
- Lead sponsor
- California State Polytechnic University, PomonaUniversity, hospital or other
- Study start
- 20 May 2017 (actual)
- Primary completion
- May 2018 (estimated)
- Study completion
- Aug 2018 (estimated)
- First posted
- 31 Jul 2017 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of the study is to examine the effect of chia seed consumption on body composition, blood pressure, blood glucose, satiety, mood, joint pain, and dietary displacement in overweight and obese females (18-45years). It is hypothesized that consuming chia seeds will bring about a positive change in body composition (lower % body fat), satiety, mood, joint pain, and blood pressure, lower blood glucose levels, increased fiber and improved nutrient intake, in overweight/ obese females.
Detailed description
Specific Objectives: 1. Determine if chia seed diet addition of 10% of Kcals (CHIA) positively changes body composition in young, healthy, overweight/obese people (Tanita scale). A) Determine if CHIA will decrease blood pressure (monitor). 2. Determine if CHIA will decrease blood glucose (draw) 3. Determine if CHIA increases satiety and improves diet (recordings). 4. Determine if CHIA will decrease joint pain (questionnaire). 5. Determine if CHIA will increase positive mood changes (questionnaires) and increase blood serotonin levels (draw).
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- Human subjects- females (18-45 y.o.) with a BMI greater than or equal to 26.
| Arm | Type | Receives |
|---|---|---|
| Chia Seeds | Active comparator | Dietary Supplement: Chia Seeds- Salvia Hispanica10% of a participants total kcal estimated needs given in chia seeds everyday for 8 weeks. |
| Control | No intervention | –Habitual diet with avoidance of high fiber and high omega-3 fatty acid foods. |
Who may qualify
- Ages
- 18 to 45 years
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (8 listed)
- are a female.
- are between the ages of 18 and 45.
- are not averse to consuming chia seeds on a regular basis (at least six weeks).
- have not taken any medication for any chronic disease (heart, diabetes, cancer) for twelve weeks.
- have not taken any steroid or hormone medication in the last eight weeks, excluding birth control pills...
Key exclusion criteria (9 listed)
- are a child, teenager, woman, or male younger than 18 or older than 45.
- eat large quantities of chia seeds on a regular basis.
- are taking any steroid or hormone medication (other than birth control pills). - are taking laxatives or fiber containing supplements on a regular basis.
- are pregnant or become pregnant.
- are currently on a diet plan.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Chia Seeds- Salvia HispanicaChia seed added-10% of kcals and a no-chia control diet. 10% will be calculated using the following formula: Harris-Benedict equation multiplied by the activity factor of 1.2, 1.375, and 1.55 depending on each participant's activity level based on the information provided on the initial screening form. | Dietary supplement | Chia Seeds |
Primary outcome
Fasting plasma glucose
Time frame: baseline
12-hour fasting plasma glucose levels will be assessed using a glucometer
Waist Circumference
Time frame: baseline
waist circumference will be measured for each participant
Caloric intake
Time frame: baseline
9, 3-day diet journals will be collected using a paper method
Serotonin
Time frame: baseline
Urine serotonin levels will be assessed
Body Weight
Time frame: Baseline
Tanita scale
Body Mass Index
Time frame: Baseline
Tanita sclae
Body Fat Percentage
Time frame: Baseline
Tanita scale
Fasting plasma glucose
Time frame: week 4
2-hour fasting plasma glucose levels will be assessed using a glucometer
Fasting plasma glucose
Time frame: week 8
2-hour fasting plasma glucose levels will be assessed using a glucometer
Waist Circumference
Time frame: week 4
waist circumference will be measured for each participant
Waist Circumference
Time frame: week 8
waist will be measured for each participant
Caloric intake
Time frame: week 4
9, 3-day diet journals will be collected using a paper method
Caloric intake
Time frame: week 8
9, 3-day diet journals will be collected using a paper method
Serotonin
Time frame: week 4
Urine serotonin levels will be assessed
Serotonin
Time frame: week 8
Urine serotonin levels will be assessed
Body Weight
Time frame: week 4
tanita scale
Body weight
Time frame: week 8
tanita scale
Body mass index
Time frame: week 4
tanita scale
body mass index
Time frame: week 8
tanita scale
Body fat percentage
Time frame: week 4
tanita scale
Body fat percentage
Time frame: week 8
tanita scale
Hip Circumference
Time frame: Baseline
Hip Circumference will be measured for each participant
Hip Circumference
Time frame: week 4
Hip Circumference will be measured for each participant
Hip Circumference
Time frame: week 8
Hip Circumference will be measured for each participant
36 secondary outcomes
Blood Pressure
Time frame: baseline
Blood Pressure
Time frame: week 4
Blood Pressure
Time frame: week 8
Joint Pain
Time frame: baseline
Joint Pain
Time frame: week 4
Joint Pain
Time frame: week 8
Mood
Time frame: Baseline
Mood
Time frame: week 4
Mood
Time frame: week 8
Physical Activity
Time frame: Baseline
Physical Activity
Time frame: week 4
Physical Activity
Time frame: week 8
Sleep Quality
Time frame: Baseline
Sleep Quality
Time frame: week 4
Sleep Quality
Time frame: week 8
Fat mass
Time frame: Baseline
Fat mass
Time frame: week 4
Fat mass
Time frame: week 8
Fat Free Mass
Time frame: Baseline
Fat Free Mass
Time frame: week 4
Fat Free Mass
Time frame: week 8
Total body water
Time frame: Baseline
Total body water
Time frame: week 4
Total body water
Time frame: week 8
Macro nutrient intake
Time frame: Baseline
Macro nutrient intake
Time frame: week 4
Macro nutrient intake
Time frame: week 8
Micronutrient intake
Time frame: Baseline
Micronutrient intake
Time frame: week 4
Micronutrient intake
Time frame: week 8
Dietary intake Satiety
Time frame: Baseline
Dietary intake Satiety
Time frame: week 4
Dietary intake Satiety
Time frame: week 8
Dietary intake displacement
Time frame: Baseline
Dietary intake displacement
Time frame: week 4
Dietary intake displacement
Time frame: week 8
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 11 May 2018.
- Individual participant dataSharing planned: No
Related trials for Obesity
RecruitingObservational study
Endoscopic Sleeve Gastroplasty (ESG) Prospective Trial for Obesity (EGO-Trial)
Obesity
Active, not recruitingPhase 4
Effects of Sequential Therapy With Mexidol® (Intravenous) and Mexidol® FORTE 250 (Oral) on Functional Brain Activity Assessed by Functional Magnetic Resonance Imaging and Biochemical Parameters in Patients With Chronic Cerebral Ischemia: A Comparison of Patients With and Without Metabolic Disorders
Metabolic Abnormalities, Obesity & Overweight
Recruiting
Exercise Training and Vitamin D Metabolism
Obesity & Overweight, Vitamin D
Recruiting
Metabolic Health, Bones and Nuts During Weight Loss in Adults
Weight Loss, Bone Density
Active, not recruiting
Effect of Probiotics on Insulin Sensitivity in Overweight and Obese Pregnancy
Obesity & Overweight, Gestational Diabetes Mellitus (GDM)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Bonny Burns-Whitmore, DrPh, RD study director
California State Polytechnic University, Pomona
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Chia Seeds- Salvia Hispanica in people with Obesity and Eating Behavior, run by California State Polytechnic University, Pomona at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 8 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 11 May 2018. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Fasting plasma glucose (time frame: baseline). The study lists 24 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 May 2018.